Latest filing published 03 Jul 2023 for Icosavax, Inc., €16k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Douglas Holtzman: trading record in brief
This profile gathers the share dealings of Douglas Holtzman in Icosavax, Inc., where the filings describe the role as senior executive. We count 17 filings; the first trade dates from 30 July 2021 and the latest from 3 July 2023.
Every open-market trade on record is a sale: 10 sales worth €566k. Outside the open market, there are 2 share grants and 2 option exercises. In 2023 alone, the filings show no purchases and 6 sales.
On 3 July 2023 came the latest disclosure, an open-market sale for €114k in Icosavax, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Douglas Holtzman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,356 shares@ US$1.041.2% of flowCommon StockSEC:0001209191-23-040716:0
- 20,443 shares@ US$1.041.5% of flowCommon StockSEC:0001209191-23-023467:0
- 1,522 shares@ US$10.69261.2% of flowCommon StockSEC:0001209191-23-009916:0
- 19,648 shares@ US$11.144315.7% of flowCommon StockSEC:0001209191-22-061736:0
- 585 shares@ US$7.10760.3% of flowCommon StockSEC:0001209191-22-044021:0
- 19,485 shares0Common StockSEC:0001209191-22-009513:0
- 41,500 shares@ US$15.0066.9% of flowCommon StockSEC:0000899243-21-031147:0
7 of 7 declarations
